Updated:
Myelin VC
Myelin VC is a venture capital firm founded in 2019 in Madrid, Spain.
Myelin VC
Myelin VC is a venture capital firm founded in 2019 in Madrid, Spain. It invests in founders across various industries, providing funding from seed to series A stages. The firm has made 60 investments, including a Series A investment in Midas on March 30, 2026.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Spain
City
Madrid
Corporate office
Madrid, Spain
Principals
Matías Nisenson
Team
Martin Varsavsky
Team
Alec Oxenford
Team
Federico Jack
Team
Gaston Maffei
Team
Catalina Plorutti
Team
Milos Fulton
Team
Cesar Levene
Team
Sector focus
Frequently asked questions
Who runs investment decisions at Myelin VC?
The investment team is composed of eight principals, all with prior founder experience. Matías Nisenson and Martin Varsavsky are the most visible partners, with Alec Oxenford, Federico Jack, Gaston Maffei, Catalina Plorutti, Milos Fulton, and Cesar Levene rounding out the group. The firm does not publicly designate a CIO or specify how investment committee votes are structured.
How does Myelin VC source its deals?
Myelin leans heavily on the personal networks of its founder-principals, who have built and exited companies across Latin America and Europe. The firm's website frames the team as 'founders-turned-investors' who 'partner with outliers,' suggesting most deal flow arrives through direct founder referrals rather than through institutional gatekeepers or pitching events.
Does Myelin VC operate as a traditional venture fund or a founder syndicate?
Myelin VC is structured as a private equity firm rather than an ad hoc syndicate, but it does not publicly disclose its fund vehicles, LP composition, or fund sizes. The partner-heavy, institutional-light model — combined with an industry-agnostic mandate — gives the firm a posture closer to a permanent-capital operator collective than a typical European VC fund.
Does Myelin VC participate in follow-on rounds after the initial check?
The firm states it invests 'from seed through series A,' implying at least one follow-on capability. However, Myelin does not publicly disclose reserve ratios or describe its follow-on strategy, leaving open the question of whether it leads later rounds or maintains pro-rata on a case-by-case basis.
What is Myelin VC's known posture on co-investments alongside external GPs?
Myelin VC has not publicly disclosed a formal co-investment program or a history of partnering with specific institutional GPs. Given its founder-network-driven approach, co-investments likely occur informally through the partners' relationships, but no named co-investors appear in the firm's published materials.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: